In a patient taking sitagliptin (Januvia) and metformin who has had episodes of hypoglycemia with blood glucose 40–70 mg/dL over several days due to reduced oral intake from nausea and vomiting, should both oral medications be held?

Hold Metformin Immediately; Januvia Can Be Continued

Yes, you should hold metformin immediately in this patient with recurrent hypoglycemia and reduced oral intake, but sitagliptin (Januvia) can generally be continued as it carries minimal hypoglycemia risk when used without insulin or sulfonylureas 1.

Medication-Specific Management During Acute Illness

Metformin - HOLD

The 2023 consensus sick day medication guidance explicitly recommends withholding metformin during acute dehydrating illnesses with nausea, vomiting, and reduced oral intake 1. The rationale includes:

• Risk of lactic acidosis in volume-depleted states
• Impaired renal clearance during dehydration increases metformin accumulation
• The patient's nausea/vomiting indicates volume depletion requiring medication cessation

Sitagliptin (Januvia) - CONTINUE (with caveats)

Sitagliptin does NOT typically cause hypoglycemia when used alone or with metformin 2. The FDA label clearly documents:

• Hypoglycemia incidence of only 1.2% with sitagliptin monotherapy vs 0.9% with placebo
• When combined with metformin alone: 1.6% hypoglycemia rate (vs 0.8% metformin alone, 0.6% placebo)
• Significant hypoglycemia occurs primarily when combined with sulfonylureas (12.2%) or insulin (15.5%) 2

The 2023 sick day guidance states that DPP-4 inhibitors should be held only if blood glucose is low, and only until blood glucose recovers 1. This is distinctly different from the blanket recommendation to hold metformin.

Critical Clinical Context

The hypoglycemia in this patient is NOT being caused by the sitagliptin-metformin combination itself - these medications together have minimal hypoglycemic risk 3, 4. The hypoglycemia is occurring because:

1. Reduced caloric intake (nausea/vomiting) without medication adjustment
2. Possible volume depletion affecting drug clearance
3. Need to rule out other causes: Verify the patient isn't accidentally taking a sulfonylurea (common medication error in elderly households 5) or other hypoglycemic agents

Practical Management Algorithm

Immediate actions:

• Hold metformin until symptoms resolve and patient resumes normal eating/drinking
• Temporarily hold sitagliptin while blood glucose remains <70 mg/dL
• Resume sitagliptin once blood glucose stabilizes >70 mg/dL and patient tolerates oral intake
• Resume metformin 24-48 hours after symptom resolution and return to normal oral intake 1

During the acute illness:

• Frequent glucose monitoring (every 2-4 hours)
• Address nausea/vomiting to restore oral intake
• Ensure adequate hydration
• Check for ketones if blood glucose becomes elevated

Common Pitfalls to Avoid

1. Don't assume the DPP-4 inhibitor is causing hypoglycemia - this is extremely rare without concomitant sulfonylurea or insulin use
2. Don't restart metformin too early - wait until the patient is eating/drinking normally for 24-48 hours
3. Verify medication reconciliation - ensure no accidental sulfonylurea ingestion (medication mix-ups are common, especially in elderly patients managing multiple household members' medications 5)
4. Don't continue metformin during volume depletion - this violates clear sick day guidance and risks lactic acidosis 1

The key distinction is that metformin requires blanket cessation during acute illness with volume depletion, while sitagliptin only needs temporary holding if hypoglycemia is present, then can be resumed once glucose normalizes 1.